FET-PET In Glioblastoma

All participants followed up until 12 months post recruitment closure

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)

Collaborating Groups

COGNO, ARTnet, ONJCRI

Participating Centres

Accrual Target

210

Current Accrual

Trial Chairperson

Prof Andrew Scott - Olivia Newton-John Cancer Research Institute (ONJCRI) / The Austin Health, VIC
A/Prof Eng-Siew Koh - Liverpool Hospital, NSW

Trial Contact

FIG@trog.com.au

Clinical Trial Registration

Related Post

August 2, 2022

Celebrating and bringing radiation medicine research to the forefront at our 2022 ASM

After a hiatus from in-person events due to COVID-19

February 28, 2022

Cancer trial participant hoping to help

The RAVES trial treating prostate cancer Participating in a